2020
DOI: 10.1016/j.apmt.2020.100730
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of hepatic differentiation of human embryonic stem cells by calcium silicate extracts for liver injury repairing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 76 publications
0
5
0
Order By: Relevance
“…Treating different sources of MSCs (BMMSCs, or UMSCs) with HGF and oncostatin could improve the efficiency of SCs differentiation toward the hepatocytes producing ALB, storage glycogen, secretion urea, uptake LDL, and increase cytochrome P450 activity [ 23 ]. Zheng et al found that using the inorganic calcium silicate optimized the ESCs differentiation into functional hepatocyte-like cells [ 24 ]. The other study showed that treating BMSCs with DLL4 (Delta-like ligand 4-mediated Notch activation contributes to reversing biliary injury) efficiently differentiated into Cholangiocytes and restores liver damage [ 25 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Treating different sources of MSCs (BMMSCs, or UMSCs) with HGF and oncostatin could improve the efficiency of SCs differentiation toward the hepatocytes producing ALB, storage glycogen, secretion urea, uptake LDL, and increase cytochrome P450 activity [ 23 ]. Zheng et al found that using the inorganic calcium silicate optimized the ESCs differentiation into functional hepatocyte-like cells [ 24 ]. The other study showed that treating BMSCs with DLL4 (Delta-like ligand 4-mediated Notch activation contributes to reversing biliary injury) efficiently differentiated into Cholangiocytes and restores liver damage [ 25 ].…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, it appears that the in vitro treatment of SCs with different factors plays a key role in the improvement of differentiation efficacy and subsequently on the therapeutic outcome. For instance, treating MSCs with plant component such as ginsenosides [ 20 ], inorganic biomaterials such as calcium silicate [ 24 ], growth factors (GFs) such as IGF [ 22 ], or GFs combination (HGF and EGF both in vitro and in vivo investigation) [ 51 ], or (HGF)/oncostatin (cytokine family member) combination [ 23 ] showed a greater differentiation of SCs into hepatocytes and would generate more functional hepatocytes. The other study showed that treating MSC with DLL4 could enhance cholangiocyte differentiation from SCs [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…To generate HLC from hESC, we adopted a hepatic differentiation protocol reported previously (supplementary figure 1(A)) [15,16,65]. The hepatic differentiation potential of hESC was first examined in 2D-cultured hESC (supplementary figure 1).…”
Section: Hepatic Differentiation Of Hesc and Characterization Of Mcol...mentioning
confidence: 99%
“…To address this, pluripotent stem cells, including human induced pluripotent stem cells and human embryonic stem cells (hESCs), have been induced to differentiate into hepatocytelike cells (HLCs) [12][13][14]. A three-step differentiation protocol mimicking the different stages of liver development (definitive endoderm (DE) differentiation, hepatic specification, and hepatocyte maturation) has been widely used for hepatic differentiation [15,16]. The highly proliferative pluripotent stem cells can yield clinically-relevant amount of HLC for the construction of 3D liver tissue [17].…”
Section: Introductionmentioning
confidence: 99%
“…Hepatic differentiation is a complex process that involves four distinct stages for stem cells (stemness maintenance (STEM), de nitive endodermal lineage (DE), precursor hepatocytes (Pre-H), and hepatocytelike cells (M-H)), each characterized by speci c cellular and molecular changes 11 . The key markers associated with the stem stage include OCT-4 and NANOG; at the DE stage, the two DE biomarkers SOX17 and CXCR4 were sound expression; the critical markers associated with Pre-H stage are AFP and SOX9; at the M-H stage, the two hepatic biomarkers ALB and CK18 were uniformly distributed inside the cells and presented over the entire cells 11,12 . Because Human hepatic stem cells are relatively di cult to obtain and their growth and differentiation rates are much slower in cell culture conditions, other cell lines were often alternatively used to study the differentiation process of human hepatic stem cells.…”
Section: Introductionmentioning
confidence: 99%